Abstract
(11.64 mM s) and GON-AN-FA (10.83 mM s) is much larger than that of the traditional positive MRI contrast agents, such as Magnevist (4.7 mM s). The results of cell viability assays indicate that the GON-AN and GON-AN-FA are almost non-cytotoxic. Furthermore, the specificities of GON-AN and GON-AN-FA were evaluated with two kinds of cancer cells that overexpress folate receptor alpha (FRα). The results reinforce that the GON-AN-FA is high-specifically-targetable to cancer cells via recognition of ligand FA and receptor FRα. In addition, the TEM and DLS results indicate that the SPION-AN-FA has a spherical shape, a uniform size and an excellent water-dispersibility (PDI b 0.05). The results of LSCM and flow cytometry demonstrate that the SPION-AN-FA is highly specific to MCF-7 and SPC-A1 cells due to the recognition of ligand FA and receptor FRα. The r1/r2 value of SPION-AN-FA is around 40, which is much higher than that of Resovist® indicating that our SPION-AN-FA has a stronger T2 shortening effect. The T2weighted images of MCF-7 cells incubated with SPION-AN-FA are significantly darker than those of MCF-7 cells incubated with AN, indicating that our SPION-AN-FA has a strong MR imaging efficacy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Nanomedicine: Nanotechnology, Biology, and Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.